New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 17, 2014
05:24 EDTSLXP, PHARMSalix, Pharming Group announces FDA approval of Ruconest
Salix Pharmaceuticals (SLXP) and Pharming Group NV (PHARM) announced that the FDA has approved Ruconest 50 IU/kg for the treatment of acute angioedema attacks in adult and adolescent patients with hereditary angioedema, or HAE. Because of the limited number of patients with laryngeal attacks, effectiveness was not established in HAE patients with laryngeal attacks.
News For SLXP;PHARM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for SLXP;PHARM

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use